About Genoox
Genoox is a Healthcare company based in Tel Aviv (Israel) founded in 2012, and was acquired by Qiagen in May 2025. Genomic data is stored and managed through a cloud-based platform. Genoox has raised $20 million across 4 funding rounds from investors including Qiagen, Triventures and Glilot. Its website genoox.com draws about 158 thousand monthly visits. Genoox offers products and services including Franklin and Data Platform. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery.
Company details
Genoox was founded in 2012 in Tel Aviv, Israel, within the clinical genomics sector. A cloud-based platform is operated for storing and managing genomic data, supporting medical experts in delivering personalized treatments based on genetic and clinical information. Researchers are assisted in identifying genetic patterns and mutation similarities. Deep learning methods and compression algorithms are utilized to address storage and analysis challenges in clinical genomics.
- Headquarters Tel Aviv, Israel
- Stage Acquired
- SectorsHealthcare
- Website genoox.com
- Social LinkedIn X Facebook
- Acquired by Qiagen (May 2025)
Products & Services of Genoox
Genoox offers a comprehensive portfolio of products and services, including Franklin and Data Platform.
Open platform for professionals to share and interpret genomic data insights.
System for fusing real-world evidence with public data for clinical applications.
Funding Insights of Genoox
Genoox has successfully raised a total of $20M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $20M
- Total Rounds 4
- First Round $6M
(Jul 2017)
- Investors Count 5
All 4 funding rounds of Genoox with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2024 | Series B | – | ArtofIn | – | |
| Jun 2021 | $8M | Series B | – | IN Venture | |
| May 2018 | $6M | Series A | – | Triventures | |
| Jul 2017 | $6M | Series A | – | Glilot Capital Partners, Inimiti | – |
6 investors in total: 6 institutional.
Investors in Genoox
Genoox has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Qiagen, Triventures and Glilot.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm investing in early stage healthcare startups | triventures.vc | Herzliya, Israel | ||
Limited information is provided about Glilot's activities. | glilotcapital.com | |||
| inimiti.net | ||||
| in-venture.com | ||||
| artofin.com | ||||
Products and reagents for molecular diagnostic assays are supplied. | 1984 | qiagen.com | Hilden, Germany |
Investor details for Genoox
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Genoox
26 people are tracked at Genoox (8 in leadership, 18 in team).
| Name | Role | Group |
|---|---|---|
Adaia Kamshov | Head of Clinical Product | Leadership |
Guy Harel | Head Of Business Operations | Leadership |
Amir Trabelsi | Co-founder and CEO | Leadership |
Oron Lev | COO And Head Of Franklin | Leadership |
Matan Levin | Director of Solutions Management | Leadership |
Tom Bensimhon | Vice President Delivery | Leadership |
Assaf Sheffer | VP Product at GENOOX | Leadership |
Itsik Bitran | Head of UX | Leadership |
noga yaffe | Product Manager | Team |
Shilat Sadan | Professional Services Engineer | Team |
Dafna Inbar | Release Manager | Team |
Shira Shai | HR Manager | Team |
Yuval Porat | Principal Engineer | Team |
Amit Mizrahi | Business Operations Manager | Team |
Michal Gabay | Full Stack Developer | Team |
Netta Kabala | Backend developer | Team |
Odem Shani | Senior Product Manager | Team |
Michael Bespalov | Senior Backend & Algorithms Developer | Team |
Irinel Pascu | Senior Software Engineer | Team |
Lilach Chaitman-Yerushalmi | Data Scientist & Algorithms Developer | Team |
6 more people are available in the full profile.
Complete people profiles for Genoox
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Genoox
4 dated milestones of Genoox across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Genoox is founded.
- Funding First funding round of $6.0M.
- Funding Latest funding round, Series B,.
- Exit Acquired by Qiagen.
Web traffic of Genoox
The website of Genoox (genoox.com) receives about 158.5K visits a month.
- Monthly visits158.5K
▲ 36.5% vs previous month
Websites whose visitors overlap most with Genoox. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
omim.org | omim.org | 100% | #90,018 | – | |
mail.google.com | mail.google.com | 57% | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genoox
Complete news archive for Genoox
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genoox
Genoox was founded in 2012 and raised its 1st funding round 5 years after it was founded.
Genoox is headquartered in Tel Aviv, Israel.
Genoox is a funded company, having raised a total of $20M across 4 funding rounds to date. The company's 1st funding round was a Series A of $6M, raised on Jul 2017.
Genoox was founded in 2012 in Tel Aviv, Israel, within the clinical genomics sector. A cloud-based platform is operated for storing and managing genomic data, supporting medical experts in delivering personalized treatments based on genetic and clinical information. Researchers are assisted in identifying genetic patterns and mutation similarities. Deep learning methods and compression algorithms are utilized to address storage and analysis challenges in clinical genomics.
Genoox offers Franklin and Data Platform.
Genoox has 6 investors. Key investors include Qiagen, Triventures, Glilot, Inimiti, and IN Venture.
Yes. Genoox was acquired by Qiagen in May 2025.
The website of Genoox receives about 158 thousand visits a month.